Biomarkers in melanoma: predisposition, screening and diagnosis.
about
Biomarkers in melanoma: stage III and IV disease.Scalp Melanoma Diagnosed by Fine Needle Aspiration Cytology in a Tertiary Health Center.Mechanism of UV-related carcinogenesis and its contribution to nevi/melanomaMelanocyte receptors: clinical implications and therapeutic relevance.Melanoma update: diagnostic and prognostic factors that can effectively shape and personalize management.Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma.
P2860
Biomarkers in melanoma: predisposition, screening and diagnosis.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Biomarkers in melanoma: predisposition, screening and diagnosis.
@ast
Biomarkers in melanoma: predisposition, screening and diagnosis.
@en
type
label
Biomarkers in melanoma: predisposition, screening and diagnosis.
@ast
Biomarkers in melanoma: predisposition, screening and diagnosis.
@en
prefLabel
Biomarkers in melanoma: predisposition, screening and diagnosis.
@ast
Biomarkers in melanoma: predisposition, screening and diagnosis.
@en
P2093
P2860
P356
P1476
Biomarkers in melanoma: predisposition, screening and diagnosis.
@en
P2093
Gerald P Linette
J Andrew Carlson
Jeffrey S Ross
Martin C Mihm
P2860
P304
P356
10.1586/14737159.3.2.163
P577
2003-03-01T00:00:00Z